Possible use of autologous stem cell therapies for Alzheimer's disease - PubMed (original) (raw)

Review

Possible use of autologous stem cell therapies for Alzheimer's disease

Kiminobu Sugaya. Curr Alzheimer Res. 2005 Jul.

Abstract

The statement, "neurodegenerative diseases are incurable because neurons do not regenerate during adulthood," has been challenged, and we have now found much evidence that the matured brain is capable of regenerating neurons. In our previous study, human neural stem cells (HNSCs) transplanted into aged rat brains differentiated into neural cells and significantly improved the cognitive functions of the animals, indicating that HNSCs may be a promising candidate for neuro-replacement therapy. However, because of ethical and practical issues associated with HNSCs, development of autologous stem cell strategies may be desired. We established new technologies to differentiate adult human mesenchymal stem cells into neural cells by modifying cell fate decisions. We also found a pyrimidine derivative that increases endogenous stem cell proliferation and neurogenesis after peripheral administrations of this compound. Although these results may promise a bright future for clinical applications of stem cell strategies in Alzheimer's disease (AD) therapy, we must acknowledge the complexity of AD. For example, abnormal metabolism of the amyloid-beta precursor protein (APP) may affect stem cell biology, while the prevalence of amyloid-beta peptide (Abeta) toxicity theory in AD pathology tends to limit our focus on the physiological functions of APP. We found that excess APP in the environment causes glial differentiation of stem cells. Even though the glial activation may be useful to eliminate Abeta deposits, neuronal differentiation of stem cells is needed for replacement of degenerating neurons in the AD brain. Thus, further investigation of the influence of AD pathology on stem cell biology is required.

PubMed Disclaimer

Cited by

In vivo imaging of embryonic stem cell therapy.
Jiang H, Cheng Z, Tian M, Zhang H. Jiang H, et al. Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):774-84. doi: 10.1007/s00259-010-1667-y. Epub 2010 Nov 24. Eur J Nucl Med Mol Imaging. 2011. PMID: 21107558 Review.
Stem cell therapies in age-related neurodegenerative diseases and stroke.
Wang Y, Ji X, Leak RK, Chen F, Cao G. Wang Y, et al. Ageing Res Rev. 2017 Mar;34:39-50. doi: 10.1016/j.arr.2016.11.002. Epub 2016 Nov 19. Ageing Res Rev. 2017. PMID: 27876573 Free PMC article. Review.
Neural Differentiation of Induced Pluripotent Stem Cells for a Xenogeneic Material-Free 3D Neurological Disease Model Neurulation from Pluripotent Cells Using a Human Hydrogel.
Valerio LSA, Carrick FR, Bedoya L, Sreerama S, Sugaya K. Valerio LSA, et al. Curr Issues Mol Biol. 2023 May 25;45(6):4574-4588. doi: 10.3390/cimb45060290. Curr Issues Mol Biol. 2023. PMID: 37367039 Free PMC article.
Alzheimer's Disease: Mechanism and Approach to Cell Therapy.
Amemori T, Jendelova P, Ruzicka J, Urdzikova LM, Sykova E. Amemori T, et al. Int J Mol Sci. 2015 Nov 4;16(11):26417-51. doi: 10.3390/ijms161125961. Int J Mol Sci. 2015. PMID: 26556341 Free PMC article. Review.
Astroglial-axonal interactions during early stages of myelination in mixed cultures using in vitro and ex vivo imaging techniques.
Ioannidou K, Anderson KI, Strachan D, Edgar JM, Barnett SC. Ioannidou K, et al. BMC Neurosci. 2014 May 2;15:59. doi: 10.1186/1471-2202-15-59. BMC Neurosci. 2014. PMID: 24886503 Free PMC article.

Possible use of autologous stem cell therapies for Alzheimer's disease - PubMed (original) (raw)